Answers are grounded in this paper and cite their sources.
OBJECTIVES: The biological response to ablative fractional laser (AFL) treatment in basal cell carcinoma (BCC) involves tissue ablation, immune activation, tissue remodeling, and wound-healing processes. However, it remains unclear whether these effects extend beyond the tissue directly affected by AFL. This study aimed to explore the spatial relationship between laser-tissue interactions and propagation of biological effects by assessing AFL-induced alterations in BCC gene expression profiles. Laser channels penetrated to approximately half of the depth of small tumors and one-third the depth of large tumors. Tumors were excised on Day 5 post-treatment and large tumors were bisected into superficial and deep regions prior to RNA extraction and sequencing. With the mouse as the unit of replication, differentially expressed genes (DEGs; DESeq.2, FDR < 0.05 and |log2 fold change| > 1) and gene set enrichment (GSEA; MSigDB Hallmark and Reactome, FDR < 0.05) were determined, and the treatment-by-depth interaction within large tumors was tested in a mouse-blocked model, followed by determination of DEGs and Ingenuity pathway analysis. RESULTS: At baseline, large tumors exhibited higher expression of cell-cycle gene sets and lower expression of interferon, complement and allograft-rejection gene sets than small tumors versus small tumors (572 and 492 DEGs for the superficial and deep halves of large tumors vs. small controls). In small tumors, AFL induced robust upregulation of immune-related genes, matrix metalloproteinases, and wound healing pathways (1061 DEGs). Notably, AFL induced a Toll-like receptor-associated transcriptional signature, akin upstream regulator predictions for Toll-like receptor agonists used in BCC therapy. In contrast, the response to AFL was markedly reduced in the superficial half of large tumors (176 DEGs) and further reduced in the deep half, beneath the AFL channels (83 DEGs), where no inflammatory gene sets were enriched. CONCLUSIONS: Our findings show that the relationship between laser settings and tumor size influences the impact of AFL therapy on BCC gene expression, consistent with AFL-induced biological effects mostly being constricted to tissue near the laser-impacted zone. These findings emphasize the importance of selecting the correct AFL fluence settings in relation to tumor size for its use in BCC management.
No takes yet. Share an insight, caveat, or question.
Olesen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: